Large-scale use of Sabin type 2 attenuated poliovirus vaccine in Singapore during a type 1 poliomyelitis epidemic.
作者信息
HALE J H, DORAISINGHAM M, KANAGARATNAM K, LEONG K W, MONTEIRO E S
出版信息
Br Med J. 1959 Jun 20;1(5137):1541-9. doi: 10.1136/bmj.1.5137.1541.
Abstract
摘要
相似文献
1
Large-scale use of Sabin type 2 attenuated poliovirus vaccine in Singapore during a type 1 poliomyelitis epidemic.
Br Med J. 1959 Jun 20;1(5137):1541-9. doi: 10.1136/bmj.1.5137.1541.
2
A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
J Virol. 2016 Jun 10;90(13):5978-88. doi: 10.1128/JVI.00277-16. Print 2016 Jul 1.
3
Some results of the work on mass immunization in the Soviet Union with live poliovirus vaccine prepared from Sabin strains.
Bull World Health Organ. 1961;25(1):79-91.
4
Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains.
Expert Rev Vaccines. 2011 May;10(5):635-44. doi: 10.1586/erv.11.51.
5
Rapid and accurate identification of poliovirus strains used for vaccine production.
J Virol Methods. 2013 Apr;189(1):189-95. doi: 10.1016/j.jviromet.2013.01.026. Epub 2013 Feb 19.
6
Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
BMC Infect Dis. 2016 Jun 10;16:277. doi: 10.1186/s12879-016-1587-y.
7
Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.
Vaccine. 2016 Apr 7;34(16):1975-85. doi: 10.1016/j.vaccine.2014.11.015. Epub 2014 Nov 21.
8
[Worldwide eradication of poliomyelitis].
Wien Klin Wochenschr. 2001 Oct 30;113(20-21):839-45.
9
10
[EXPERIMENTS ON VIRAL EXCRETION AND SERUM DIFFERENTIATION DURING A POLIOMYELITIS EPIDEMIC FOLLOWING ORAL VACCINATION WITH POLIOVIRUS TYPE-3].
Klin Wochenschr. 1965 May 15;43:570-3. doi: 10.1007/BF01485122.
引用本文的文献
1
Chapter 4 Picornavirus infections.
Perspect Med Virol. 1985;1:127-186. doi: 10.1016/S0168-7069(08)70012-0. Epub 2008 May 29.
2
Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial.
Lancet Infect Dis. 2015 Aug;15(8):889-97. doi: 10.1016/S1473-3099(15)00093-6. Epub 2015 Jun 17.
3
ANNOTATIONS.
Br Med J. 1960 Feb 27;1(5173):627-30.
4
Live Poliomyelitis Vaccines.
Br Med J. 1959 Oct 3;2(5152):624-5.
5
A selected public health bibliography with annotations.
Am J Public Health Nations Health. 1959 Sep;49(9):1281-3. doi: 10.2105/ajph.49.9.1281.
6
1963 EPIDEMIC OF POLIOMYELITIS IN BARBADOS, WEST INDIES.
Public Health Rep (1896). 1965 May;80(5):423-31.
7
[USE OF HOMOTYPIC ORAL ANTIPOLIOMYELITS VACCINATION IN AN EPIDEMIC CAUSED BY TYPE I POLIOMYELITIS VIRUS IN FRANCE].
Bull World Health Organ. 1964;30(5):663-74.
8
POLIOMYELITIS IN DUNDEE, 1962.
Br Med J. 1964 Oct 3;2(5413):853-7. doi: 10.1136/bmj.2.5413.853.
9
PREVENTION OF POLIOMYELITIS IN SINGAPORE BY LIVE VACCINE.
Br Med J. 1964 Apr 25;1(5390):1077-80. doi: 10.1136/bmj.1.5390.1077.
10
Poliomyelitis epidemic in Mauritius and the effect of vaccination.
Br Med J. 1960 Oct 29;2(5208):1272-6. doi: 10.1136/bmj.2.5208.1272.
本文引用的文献
1
A small-scale trial of type III attenuated living poliovirus vaccine.
Br Med J. 1958 Nov 15;2(5106):1188-93. doi: 10.1136/bmj.2.5106.1188.
2
Properties and behavior of orally administered attenuated poliovirus vaccine.
J Am Med Assoc. 1957 Jul 13;164(11):1216-23. doi: 10.1001/jama.1957.62980110008008.
3
Vaccination against poliomyelitis with live virus vaccines. III. The evaluation to TN and SM virus vaccines.
Br Med J. 1957 Jan 12;1(5010):70-4.
4
Vaccination against poliomyelitis with live virus vaccines. II. A trial of SM type I attenuated poliomyelitis virus vaccine.
Br Med J. 1957 Jan 12;1(5010):65-70.
5
Present status of attenuated live-virus poliomyelitis vaccine.
J Am Med Assoc. 1956 Dec 29;162(18):1589-96. doi: 10.1001/jama.1956.02970350005002.
6
Living attenuated poliomyelitis virus as an immunizing agent of man.
S Afr Med J. 1955 Oct 29;29(49):1134-42.
Zotero 插件